Market Cap

I-Mab Market Capitalization:

$129.4 Million

USD as of July 1, 2024

business I-Mab Company Profile

I-Mab Main Stock Listing

NASDAQ: IMAB

Market Capitalization History of I-Mab

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of I-Mab market cap

Date Market Cap YoY Change
Jan. 1, 2024 $176.0 M -68.46%
Jan. 1, 2023 $558.0 M -72.87%
Jan. 1, 2022 $2.06 B -53.58%
Jan. 1, 2021 $4.43 B 342.20%
Jan. 1, 2020 $1.00 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

I-Mab Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

I-Mab has the following listings and related stock indices.


Stock: NASDAQ: IMAB

Stock: FSX: 0VY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.